← back to search

Ling Hai

Mongolian National University of Medical Sciences ·
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Pleural and Pulmonary Diseases, Glioma Diagnosis and Treatment, Angiogenesis and VEGF in Cancer, and Single-cell and spatial transcriptomics.
h-index
14
citations
1,314
works
74
NIH funding
primary concept
Medicine
email

Recent publications

Development of a fully human glioblastoma-in-brain-spheroid model for accelerated translational research
Journal of Advanced Research 2025cited by 5position: middledoi
Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma
Cancer Letters 2024cited by 7position: middledoi
Pleural pro-gastrin releasing peptide is a potential diagnostic marker for malignant pleural effusion induced by small-cell lung cancer
Journal of Thoracic Disease 2024cited by 7position: middledoi
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression
Neuro-Oncology 2023cited by 51position: middledoi
Oncogenic RAS-Pathway Activation Drives Oncofetal Reprogramming and Creates Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 1position: middledoi
Glioblastoma hijacks neuronal mechanisms for brain invasion
Cell 2022cited by 586position: middledoi
Autonomous rhythmic activity in glioma networks drives brain tumour growth
Nature 2022cited by 242position: middledoi
A connectivity signature for glioblastoma
WFNOS 2022 Abstract Book 2022cited by 1position: middledoi
Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasis
Science Translational Medicine 2021cited by 95position: middledoi
A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma
Neuro-Oncology 2021cited by 40position: middledoi
A connectivity signature for glioblastoma
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 10position: firstdoi
Tumor cell network integration in glioma represents a stemness feature
Neuro-Oncology 2020cited by 44position: middledoi
Timed Ang2-Targeted Therapy Identifies the Angiopoietin–Tie Pathway as Key Regulator of Fatal Lymphogenous Metastasis
Cancer Discovery 2020cited by 33position: middledoi
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
Neuro-Oncology Advances 2020cited by 20position: middledoi
BIOM-39. ESTABLISHMENT OF A CONNECTIVITY SIGNATURE FOR GLIOMAS
Neuro-Oncology 2020cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wolfgang Wick · Heidelberger Institut für Radioonkologie9 papers (2020–2025)Tobias Keßler · German Cancer Research Center8 papers (2020–2024)Frank Winkler · TU Dresden7 papers (2020–2025)Matthias Schlesner · University of Augsburg7 papers (2020–2022)Dirk C. Hoffmann · German Cancer Research Center6 papers (2020–2025)Christel Herold‐Mende · German Cancer Research Center5 papers (2020–2024)Felix Sahm · Heidelberg (Poland)5 papers (2020–2024)Erik Jung · German Cancer Research Center4 papers (2020–2023)Henriette Mandelbaum · Universitätsklinikum Erlangen4 papers (2020–2023)Varun Venkataramani · DKFZ-ZMBH Alliance4 papers (2020–2023)Daniel Domínguez Azorín · The Geneva Association4 papers (2021–2025)Ruifan Xie · Heidelberg University4 papers (2020–2022)Rainer Will · German Cancer Research Center2 papers (2021–2022)Junhao Hu · Northeast Petroleum University2 papers (2020–2021)Mario L. Suvà · Harvard University2 papers (2021–2022)Gergely Solecki · Deutschen Konsortium für Translationale Krebsforschung2 papers (2020–2023)Hellmut G. Augustin · Heidelberg Engineering (Germany)2 papers (2020–2021)Jakob Ito · Heidelberg University2 papers (2021–2022)Emma Phillips · Royal Marsden NHS Foundation Trust2 papers (2021–2024)Obada Alhalabi · Heidelberg University2 papers (2021–2024)